SCANGOS GEORGE A — SEC Form 4 filings
SEC reporting owner CIK 1202102. 13 Form 4 filings on record with FilingPulse; latest filed 2026-06-11.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-02-20 to 2026-06-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 4 filings — 76,520 shares, $793,669 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 17,722 shares @ $11.65 ($206,522) in Vir Biotechnology, Inc., filed 2024-02-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | Director | 6 | — | 6 legs · 76,520 sh · $793,669 | 6 |
| AGILENT TECHNOLOGIES, INC. (A) | Director | 4 | — | — | 6 |
| Voyager Therapeutics, Inc. (VYGR) | Director | 3 | — | — | 3 |
Form 4 filings — SCANGOS GEORGE A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-11 | 4 | Voyager Therapeutics, Inc. (VYGR) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-03-23 | 4 | AGILENT TECHNOLOGIES, INC. (A) | Grant/award (A): 2,158 @ $111.75 · Grant/award (A): 1,057 @ $111.75 | EDGAR |
| 2025-06-04 | 4 | Voyager Therapeutics, Inc. (VYGR) | Grant/award (A): 24,000 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | AGILENT TECHNOLOGIES, INC. (A) | Grant/award (A): 1,819 @ $121.18 | EDGAR |
| 2025-02-25 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 10,056 @ $9.45 | EDGAR |
| 2025-02-19 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 10,964 @ $9.81 | EDGAR |
| 2024-10-24 | 4 | Vir Biotechnology, Inc. (VIR) | Other (J): 598,270 @ $0 · Other (J): 598,270 @ $0 · Other (J): 598,270 @ $0 · Other (J): 598,270 @ $0 | EDGAR |
| 2024-06-07 | 4 | Voyager Therapeutics, Inc. (VYGR) | Grant/award (A): 24,000 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 8,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2024-05-31 | 4 | AGILENT TECHNOLOGIES, INC. (A) | Gift (G): 3,443 @ $145.48 · Gift (G): 3,443 @ $145.48 | EDGAR |
| 2024-03-19 | 4 | AGILENT TECHNOLOGIES, INC. (A) | Grant/award (A): 1,678 @ $147.48 | EDGAR |
| 2024-02-26 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 10,028 @ $10.05 · Sale (S): 17,722 @ $11.65 | EDGAR |
| 2024-02-20 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 10,878 @ $10.24 · Sale (S): 16,872 @ $10.22 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1202102 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →